New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.00 -0.09 (0.89%)
Previous Close $10.09    52 Week High $2.18 
Open $10.47    52 Week Low $0.30 
Day High $10.47    P/E N/A 
Day Low $10.00    EPS $-3.32 
Volume 140,828       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.00 -0.09 (0.89%)
Previous Close $10.09    52 Week High $2.18 
Open $10.47    52 Week Low $0.30 
Day High $10.47    P/E N/A 
Day Low $10.00    EPS $-3.32 
Volume 140,828